Follow
Daniel Schmolze
Daniel Schmolze
City of Hope Comprehensive Cancer Center
Verified email at coh.org
Title
Cited by
Cited by
Year
Assessment of breast pathologies using nonlinear microscopy
YK Tao, D Shen, Y Sheikine, OO Ahsen, HH Wang, DB Schmolze, ...
Proceedings of the National Academy of Sciences 111 (43), 15304-15309, 2014
2152014
Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer
L Wang, DL Simons, X Lu, TY Tu, S Solomon, R Wang, A Rosario, ...
Nature immunology 20 (9), 1220-1230, 2019
1452019
Comprehensive profiling of poor-risk paired primary and recurrent triple-negative breast cancers reveals immune phenotype shifts
KE Hutchinson, SE Yost, CW Chang, RM Johnson, AR Carr, PR McAdam, ...
Clinical Cancer Research 26 (3), 657-668, 2020
862020
Raman spectroscopy for rapid evaluation of surgical margins during breast cancer lumpectomy
WC Z˙˝iga, V Jones, SM Anderson, A Echevarria, NL Miller, C Stashko, ...
Scientific reports 9 (1), 14639, 2019
782019
Advances in microscopy techniques
DB Schmolze, C Standley, KE Fogarty, AH Fischer
Archives of pathology & laboratory medicine 135 (2), 255-263, 2011
762011
EMDomics: a robust and powerful method for the identification of genes differentially expressed between heterogeneous classes
S Nabavi, D Schmolze, M Maitituoheti, S Malladi, AH Beck
Bioinformatics 32 (4), 533-541, 2016
722016
Characterization and analysis of the composition and dynamics of the mammalian riboproteome
M Reschke, JG Clohessy, N Seitzer, DP Goldstein, SB Breitkopf, ...
Cell reports 4 (6), 1276-1287, 2013
652013
Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application
A Echle, NG Laleh, P Quirke, HI Grabsch, HS Muti, OL Saldanha, ...
ESMO open 7 (2), 100400, 2022
632022
A phase II clinical trial of pembrolizumab and enobosarm in patients with androgen receptor‐positive metastatic triple‐negative breast cancer
Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, ...
The oncologist 26 (2), 99-e217, 2021
572021
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer
Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, ...
European Journal of Cancer 154, 11-20, 2021
442021
Direct comparison between confocal and multiphoton microscopy for rapid histopathological evaluation of unfixed human breast tissue
T Yoshitake, MG Giacomelli, LC Cahill, DB Schmolze, H Vardeh, ...
Journal of biomedical optics 21 (12), 126021-126021, 2016
432016
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study
SJ Wagner, D ReisenbŘchler, NP West, JM Niehues, J Zhu, S Foersch, ...
Cancer Cell 41 (9), 1650-1661. e4, 2023
382023
Crowdsourcing scoring of immunohistochemistry images: Evaluating performance of the crowd and an automated computational method
H Irshad, EY Oh, D Schmolze, LM Quintana, L Collins, RM Tamimi, ...
Scientific reports 7 (1), 43286, 2017
382017
Mutation and immune profiling of metaplastic breast cancer: correlation with survival
M Afkhami, D Schmolze, SE Yost, PH Frankel, A Dagis, IU Amanam, ...
PLoS One 14 (11), e0224726, 2019
352019
Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer
JS Lee, SE Yost, S Blanchard, D Schmolze, HH Yin, R Pillai, K Robinson, ...
Breast Cancer Research 21, 1-13, 2019
332019
Accuracy of gross intraoperative margin assessment for breast cancer: experience since the SSO-ASTRO margin consensus guidelines
A Nunez, V Jones, K Schulz-Costello, D Schmolze
Scientific Reports 10 (1), 17344, 2020
322020
Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple‐Negative Breast Cancer
Y Yuan, JS Lee, SE Yost, SM Li, PH Frankel, C Ruel, D Schmolze, ...
The Oncologist 26 (3), e382-e393, 2021
312021
Towards integration of 64Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancer
AM Jarrett, DA Hormuth, V Adhikarla, P Sahoo, D Abler, L Tumyan, ...
Scientific Reports 10 (1), 20518, 2020
312020
Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis
TF He, SE Yost, PH Frankel, A Dagis, Y Cao, R Wang, A Rosario, TY Tu, ...
PLoS One 15 (3), e0229955, 2020
312020
Identification of tissue-specific DNA methylation signatures for thyroid nodule diagnostics
JH Yim, AH Choi, AX Li, H Qin, S Chang, SWT Tong, P Chu, BW Kim, ...
Clinical Cancer Research 25 (2), 544-551, 2019
302019
The system can't perform the operation now. Try again later.
Articles 1–20